Free Trial

Regencell Bioscience (RGC) SEC Filings & 10K Form

Regencell Bioscience logo
$14.75 -1.82 (-10.98%)
As of 07/11/2025 04:00 PM Eastern

Recent Regencell Bioscience SEC Filings

DateFilerForm TypeView
06/30/2025
8:00 AM
Regencell Bioscience (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/30/2025
8:10 AM
Regencell Bioscience (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/17/2025
5:08 AM
Regencell Bioscience (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/02/2025
5:28 AM
Regencell Bioscience (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/13/2025
5:16 AM
Regencell Ltd (0001874958) (Filed by)
Regencell Bioscience (Subject)
Form SCHEDULE 13D/A
01/15/2025
5:02 AM
Regencell Bioscience (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/25/2024
3:15 PM
Regencell Bioscience (Filer)
Form 20-F
Registration statement / Annual report / Transition report  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:RGC) was last updated on 7/13/2025 by MarketBeat.com Staff
From Our Partners